DK2417152T3 - Fremgangsmåde til isolering af linaclotid - Google Patents

Fremgangsmåde til isolering af linaclotid

Info

Publication number
DK2417152T3
DK2417152T3 DK10715185.4T DK10715185T DK2417152T3 DK 2417152 T3 DK2417152 T3 DK 2417152T3 DK 10715185 T DK10715185 T DK 10715185T DK 2417152 T3 DK2417152 T3 DK 2417152T3
Authority
DK
Denmark
Prior art keywords
linaclotide
isolating
isolating linaclotide
Prior art date
Application number
DK10715185.4T
Other languages
English (en)
Inventor
Michael Paul Fleming
Raymond Dennis Petersen
Original Assignee
Corden Pharma Colorado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42289374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2417152(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corden Pharma Colorado Inc filed Critical Corden Pharma Colorado Inc
Application granted granted Critical
Publication of DK2417152T3 publication Critical patent/DK2417152T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DK10715185.4T 2009-04-10 2010-04-07 Fremgangsmåde til isolering af linaclotid DK2417152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16825909P 2009-04-10 2009-04-10
PCT/EP2010/054577 WO2010115916A1 (en) 2009-04-10 2010-04-07 Process for isolating therapeutic peptide

Publications (1)

Publication Number Publication Date
DK2417152T3 true DK2417152T3 (da) 2013-12-16

Family

ID=42289374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10715185.4T DK2417152T3 (da) 2009-04-10 2010-04-07 Fremgangsmåde til isolering af linaclotid

Country Status (7)

Country Link
US (1) US20100261877A1 (da)
EP (1) EP2417152B1 (da)
CN (1) CN102482326A (da)
DK (1) DK2417152T3 (da)
ES (1) ES2439998T3 (da)
IL (1) IL215562A0 (da)
WO (1) WO2010115916A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2605786A4 (en) * 2010-06-09 2014-03-12 Combimab Inc THERAPEUTIC PEPTIDES
CA3100941C (en) * 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US20140018307A1 (en) * 2012-07-12 2014-01-16 Forest Laboratories Holdings Ltd. Linaclotide compositions
CN103848893B (zh) * 2012-12-07 2016-08-10 深圳翰宇药业股份有限公司 一种利那洛肽的纯化方法
EP2950803A1 (en) 2013-01-30 2015-12-09 Sandoz AG Crystalline form of linaclotide
CN104231051B (zh) * 2013-06-06 2020-06-26 深圳翰宇药业股份有限公司 一种利那洛肽的制备方法
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2016012938A2 (en) * 2014-07-22 2016-01-28 Dr. Reddy’S Laboratories Limited Improved process for preparation of amorphous linaclotide
WO2014188011A2 (en) * 2014-09-25 2014-11-27 Lonza Ltd Method for preparation of linaclotide
CN110878118B (zh) * 2018-09-06 2023-04-18 深圳翰宇药业股份有限公司 度拉糖肽的纯化方法与纯化试剂
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
KR100464208B1 (ko) * 2001-12-20 2005-01-03 엘지.필립스 엘시디 주식회사 액정 표시장치 및 그 구동방법
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)
US20040028747A1 (en) * 2002-08-06 2004-02-12 Tucker Christopher J. Crystalline drug particles prepared using a controlled precipitation process
EP1594517B1 (en) * 2003-01-28 2007-06-20 Microbia, Inc. Compositions for the treatment of gastrointestinal disorders
US7371727B2 (en) 2003-01-28 2008-05-13 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
EP2417152B1 (en) 2013-10-02
CN102482326A (zh) 2012-05-30
ES2439998T3 (es) 2014-01-27
US20100261877A1 (en) 2010-10-14
EP2417152A1 (en) 2012-02-15
IL215562A0 (en) 2011-12-29
WO2010115916A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
DK2417152T3 (da) Fremgangsmåde til isolering af linaclotid
DK2408561T3 (da) Fremgangsmåde til isolering af partikler
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
FI20090389A0 (fi) Menetelmä
DK2601542T3 (da) Fremgangsmåde til at adskille uafhængige samtidige kilder
DK2513135T3 (da) Fremgangsmåde til oprensning af polypeptider
DK2283904T3 (da) Komponentsystem
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
HK1170318A1 (en) Input method editor
DK3543333T3 (da) Fremgangsmåde til screening af alfa-amylaser
DK2509427T3 (da) Fremgangsmåder til fremstilling af GH8-xylanasevarianter
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK2580156T4 (da) Fremgangsmåde til lagring af hydrogen
BRPI0919116A2 (pt) método
DK2398817T4 (da) Fremgangsmåde til rensning af lipopeptider
BRPI1012526A2 (pt) método
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
BRPI1010705A2 (pt) método
DK2557988T3 (da) System til forudsigelse af gastrointestinal dysfunktion
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK2313489T3 (da) Fremstillingsmetode
HK1169191A1 (zh) 輸入法編輯器
DK2313364T3 (da) Fremgangsmåder til detektering af symmetrisk demethylarginin